| Regor Pharmaceuticals (USA). (9/30/24). "Press Release: Regor Enters into a Definitive Purchase Agreement for Genentech to Acquire Regor's Portfolio of Next-generation CDK Inhibitors for the Treatment of Breast Cancer". Cambridge, MA. |
2024-09-30 |
| Tempus AI, Inc.. (9/26/24). "Press Release: Tempus Announces Expansion of Collaboration with Takeda to Leverage Multimodal Real-world Datasets and Biological Model Systems in Oncology Research and Development". Chicago, IL. |
2024-09-26 |
| Resonac Corporation. (9/24/24). "Press Release: Resonac Corporation Signs Contract to Transfer Shares of Minaris Regenerative Medicine Subsidiaries to Altaris". Zwingenberg. |
2024-09-24 |
| Aptadir Therapeutics. (9/24/24). "Press Release: Launch of Aptadir Therapeutics With a Novel Class of RNA Inhibitors". Milan. |
2024-09-24 |
| Minaris Regnerative Medicine GmbH. (9/24/24). "Press Release: Minaris Regenerative Medicine Announces Agreement to be Acquired by Altaris". Yokohama, Munich & Allendale, NJ. |
2024-09-24 |
| Symrise AG. (9/20/24). "Press Release: Symrise and Shan Foods Inaugurate a State-of-the-Art International Standard Production Facility for Its Strategic Partnership in Pakistan". Dubai, Holzminden & Karachi. |
2024-09-20 |
| Bioké (Cell Signaling Technology Europe B.V.). (9/16/24). "Press Release: Bioké and e-Blot Announce a Distribution Agreement in the European Region". Leiden. |
2024-09-16 |
| Abolis Biotechnologies SAS. (9/12/24). "Press Release: Abolis Biotechnologies Secures 35 Mio. Euro from International Consortium of Industrials and Funds". Èvry-Courcouronnes. |
2024-09-12 |
| Organon & Co.. (9/12/24). "Press Release: Organon Enters into Licensing Agreement with Bao Pharmaceutical and Its Wholly-owned Subsidiary Centergene Pharmaceuticals". Shanghai. |
2024-09-12 |
| Singleron Biotechnologies. (9/11/24). "Press Release: Singleron Launches New All-in-One sCelLiVE Tissue Dissociation Kit for Skin". Cologne. |
2024-09-11 |
| PhoreMost Ltd.. (9/10/24). "Press Release: PhoreMost Extends Series B Financing to $50M to Advance High-value Oncology and Inflammation Degrader Programmes". Cambridge. |
2024-09-10 |
| Oxford Nanopore Technologies plc. (9/10/24). "Press Release: Oxford Nanopore Seeks Discovery in Connection with Anticipated Breach of Contract Action". |
2024-09-10 |
| Körber Pharma. (9/4/24). "Press Release: Körber Reaches Strategic Partnership with Taibang Biologic to Future-proof Blood Product Manufacturing and Increase Production Efficiency". Lüneburg & Tai’an. |
2024-09-04 |
| EpimAb Biotherapeutics, Inc.. (9/4/24). "Press Release: EpimAb Biotherapeutics and Vignette Bio Announce Strategic Collaboration to Develop EMB-06, a BCMA×CD3 Bispecific Antibody". Shanghai & San Diego, CA. |
2024-09-04 |
| Nxera Pharma Co., Ltd.. (9/2/24). "Press Release: Nxera Pharma to Receive US$35 Million from Neurocrine Biosciences upon Positive Phase 2 Data for Partnered Schizophrenia Candidate NBI-1117568". Tokyo & Cambridge. |
2024-09-02 |
| Boehringer Ingelheim. (8/30/24). "Press Release: Boehringer Ingelheim Announces Appointments Board of Managing Directors". Ingelheim. |
2024-08-30 |
| BioArctic AB. (8/22/24). "Press Release: Leqembi (lecanemab) Authorized for Early Alzheimer’s Disease in Great Britain". Stockholm. |
2024-08-22 |
| Vandria S.A.. (8/21/24). "Press Release: Hevolution Foundation and Dolby Family Ventures Join Vandria’s 2nd Series A Closing, Bringing the Total round to $30.7M (CHF 28.3M) to Progress the Mitophagy Inducer VNA-318 into CNS Clinical Development". Lausann |
2024-08-21 |
| Fujifilm Diosynth Biotechnologies UK Ltd.. (8/20/24). "Press Release: Fujifilm Diosynth Biotechnologies Celebrates Opening of Billingham, UK Microbial Manufacturing Facility". Billingham. |
2024-08-20 |
| Adcendo ApS. (8/20/24). "Press Release: Adcendo ApS and Multitude Therapeutics Inc. Announce Global Development and Commercialization Agreement on First-in-class ADC Drug Candidate Targeting Tissue Factor". Copenhagen & Shanghai. |
2024-08-20 |
| BioNTech SE. (8/19/24). "Press Release: Lift of Partial Clinical Hold for BNT326/YL202". |
2024-08-19 |
| PL BioScience GmbH. (8/8/24). "Press Release: PL BioScience Closes € 7.8 million Series A Financing". Aachen. |
2024-08-08 |
| Medigene AG. (8/8/24). "Press Release: Medigene and WuXi Biologics Enter into a Research Collaboration for Off-the-Shelf TCR-Guided T Cell Engagers". Planegg-Martinsried. |
2024-08-08 |
| AGC Biologics. (8/7/24). "Press Release: NEC Bio Therapeutics and AGC Biologics Announce Collaboration to Manufacture Personalized Cancer Vaccines". |
2024-08-07 |
| Leon-Nanodrugs GmbH. (8/6/24). "Press Release: Leon-Nanodrugs Secures Funds in a Series D Financing to Broaden Portfolio in First Single-use High Throughput Production Systems for Nanoencapsulation". Munich. |
2024-08-06 |
| Biomatter Designs. (8/5/24). "Press Release: Biomatter Raises a €6.5 Million Seed Round to Unlock the Power of Generative AI for Enzyme Design". Vilnius. |
2024-08-05 |
| AIRNA Corporation. (7/31/24). "Press Release: AIRNA Raises Oversubscribed $60 Million Financing to Advance New Class of RNA Editing Medicines and Progress Best-in-Class AATD Program into the Clinic". Cambridge, MA & Tübingen. |
2024-07-31 |
| Systasy Bioscience GmbH. (7/31/24). "Press Release: Systasy Bioscience Announces Collaboration Agreement with Ono Pharmaceutical". Munich. |
2024-07-31 |
| iotaSciences Ltd.. (7/31/24). "Press Release: iotaSciences Raises Equity Financing Round to Drive further Business Expansion for Its Automated Single-cell Biology Handling Technologies". Oxford. |
2024-07-31 |
| Shenzhen Synthetica Pioneering Co., Ltd.. (7/30/24). "Press Release: Synthetica Pioneering Closes a Series A Funding Round to Support Development of Oncolytic Bacterial Therapy for Solid Tumors". Shenzhen. |
2024-07-30 |
| 65LAB. (7/29/24). "Press Release: 65LAB and Duke-NUS Award US$1.85 Million to Combat Chronic Inflammation". Singapore. |
2024-07-29 |
| Revir Therapeutics. (7/26/24). "Press Release: Revir Therapeutics Raises $30 Million Series A Financing to Advance its Proprietary Oral Genetic Medicines for Multiple CNS Disorders". Brisbane, CA. |
2024-07-26 |
| Triastek, Inc.. (7/23/24). "Press Release: Triastek Announces Research Collaboration and Platform Technology License Agreement with BioNTech to Advance 3D Printed Oral RNA Therapeutics". Nanjing. |
2024-07-23 |
| Pinetree Therapeutics, Inc.. (7/23/24). "Press Release: Pinetree Therapeutics Announces Exclusive Option and Global License Agreement for Preclinical EGFR Degrader Candidate with AstraZeneca". Cambridge, MA. |
2024-07-23 |
| Valneva S.E.. (7/22/24). "Press Release: CEPI Expands Partnership with Valneva with a $41.3 Million Grant to Support Broader Access to the World’s First Chikungunya Vaccine". Oslo & Saint-Herblain. |
2024-07-22 |
| Full-Life Technologies. (7/17/24). "Press Release: Full-Life Technologies, SK Biopharmaceuticals Enter Licensing Agreement for Novel Therapeutic Targeting Multiple Solid Tumors". Heidelberg & Seoul. |
2024-07-17 |
| CytoReason Ltd.. (7/17/24). "Press Release: CytoReason Secures $80M from OurCrowd, NVIDIA, Pfizer, and Thermo Fisher Scientific to Scale Its AI Disease Models and Establish US Hub in Cambridge, Massachusetts". Tel Aviv. |
2024-07-17 |
| Draupnir Bio ApS. (7/1//24). "Press Release: Draupnir Bio Completes €12 Million Seed Round to Progress Development of Oral Small Molecule Degraders of Extracellular Proteins". Copenhagen. |
2024-07-17 |
| Catalym GmbH. (7/16/24). "Press Release: Catalym Announces New Financing of $150M to Support Broad Phase 2b Development Program for Visugromab". Munich. |
2024-07-16 |
| Sotio Biotech a.s.. (7/16/24). "Press Release: Sotio Enters into Multi-Target Antibody Agreement with Biocytogen to Expand ADC Pipeline". Prague & Beijing. |
2024-07-16 |
| Scorpion Therapeutics, Inc.. (7/16/24). "Press Release: Scorpion Therapeutics Announces $150 Million Series C Financing to Advance Leading Clinical-stage Precision Oncology Pipeline". Boston, MA. |
2024-07-16 |
| Huma Therapeutics Ltd.. (7/16/24). "Press Release: Huma Completes Series D with Total Financing of over $80m as It Launches Huma Cloud Platform with GenAI Integrations to Bring Digital First Care and Research to Everyone". London & New York, NY. |
2024-07-16 |
| Ipsen S.A.. (7/11/24). "Press Release: Ipsen and Foreseen Biotechnology Announce Exclusive Global Licensing Agreement for Antibody-Drug Conjugate with First-in-Class Potential". Paris. |
2024-07-11 |
| Element Biosciences, Inc.. (7/11/24). "Press Release: Element Biosciences Raises Over $277 Million to Develop and Commercialize Differentiated Products and Continue Rapid Growth". San Diego, CA. |
2024-07-11 |
| Endoron Medical Ltd.. (7/9/24). "Press Release: Endoron Medical Raises $10 Million in Series A Funding Led by Sofinnova Partners to Accelerate the Validation of Its AAA EndoStapling Solution Aortoseal". Tel Aviv. |
2024-07-09 |
| Myricx Pharma Ltd.. (7/8/24). "Press Release: Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development". London. |
2024-07-08 |
| Full-Life Technologies. (7/3/24). "Press Release: Full-Life Technologies Granted FDA Fast Track Designation for 225Ac-FL-020 for the Treatment of Metastatic Castration-Resistant Prostate Cancer". Heidelberg. |
2024-07-03 |
| Sartorius AG. (7/2/24). "Press Release: Sartorius AG – After more than 20 Years as CEO, Joachim Kreuzburg Will Not Pursue another Term in Office – Supervisory Board Expresses Great Regret". Göttingen. |
2024-07-02 |
| Proscia Inc.. (6/25/24). "Press Release: Proscia and Nucleai Partner to Broaden Access to AI Predictive Biomarkers". Philadeliphia, PA & Chicago, IL. |
2024-06-25 |
| BioNTech SE. (6/24/24). "Press Release: BioNTech and DualityBio Receive FDA Fast Track Designation for Antibody-Drug Conjugate Candidate BNT324/DB-1311 in Prostate Cancer". Mainz & Shanghai. |
2024-06-24 |
| Santhera Pharmaceuticals Holding AG. (6/18/24). "Press Release: Santhera Secures up to CHF 69 million in Royalty and Debt Financing to Fund Operations to Cash Flow Break-Even (Ad hoc announcement pursuant to Art. 53 LR)". Pratteln. |
2024-06-18 |
| Ethris GmbH. (6/18/24). "Press Release: Cipla EU to Invest an Additional EUR 3 Million in Ethris". Mumbai & Munich. |
2024-06-18 |
| Adcytherix SAS. (6/11/24). "Press Release: Adcytherix Launches with € 30m in Seed Funding to Develop Next Generation Antibody Drug Conjugates". Marseille. |
2024-06-11 |
| Macomics Ltd.. (6/10/24). "Press Release: Macomics Announces Appointment of Simon Dew as New Chief Business Officer". Edinburgh & Cambridge. |
2024-06-10 |
| ITM Isotope Technologies Munich SE. (6/6/24). "Press Release: ITM Raises €188m to Enhance Radiopharmaceutical Pipeline and to Strengthen Leading Position in Medical Radioisotope Manufacturing". Garching. |
2024-06-06 |
| Annogen B.V.. (6/4/24). "Press Release: Annogen Announces Research Collaboration with Orchard Therapeutics for the Development of CNS-cell Specific Promoters". Amsterdam. |
2024-06-04 |
| Brandon Capital. (6/4/24). "Press Release: Brandon Capital Announces Sixth Fund with A$270 Million (US$180 Million) Initial Close to Drive Life Science Innovation". Melbourne. |
2024-06-04 |
| Bionova Scientific. (6/3/24). "Press Release: Bionova Scientific Announces Plans for New Plasmid DNA GMP Facility". Fremont, CA. |
2024-06-03 |
| Merck & Co., Inc.. (5/29/24). "Press Release: Merck to Acquire EyeBio". Rahway, NJ & New York, NY. |
2024-05-29 |
| Adcendo ApS. (5/29/24). "Press Release: Adcendo ApS Announces Extension of Series A Financing to EUR 98M to Further Bolster its First-in-Class ADC Pipeline". Copenhagen. |
2024-05-29 |
| Fresenius SE & Co. KGaA. (5/29/24). "Press Release: Fresenius Appoints Internationally Experienced Biopharma Expert to the Fresenius Kabi Management Board". |
2024-05-29 |
| Merck KGaA. (5/29/24). "Press Release: Merck Signs MoU with KAIST to Advance Scientific Collaboration". Darmstadt. |
2024-05-29 |
| TVM Capital Healthcare. (5/28/24). "Press Release: TVM Capital Healthcare Announces the Closing of Its Saudi Arabia-Focused TVM Healthcare Afiyah Fund
". Riyadh. |
2024-05-28 |
| Asahi Kasei Corporation. (5/28/24). "Press Release: Asahi Kasei to Acquire Calliditas Therapeutics AB to Accelerate Growth as a Global Healthcare Company". |
2024-05-28 |
| Hitachi High-Tech Corporation. (5/27/24). "Press Release: Roche and Hitachi High-Tech Extend Their Long-standing Partnership". Tokyo. |
2024-05-27 |
| Daiichi Sankyo Co., Ltd.. (5/22/24). "Press Release: Daiichi Sankyo Establishes Two Research Institutes in the U.S. and EU". |
2024-05-22 |
| LabGenius. (5/21/24). "Press Release: LabGenius Raises £35 Million Led by M Ventures to Further Develop Its ML-driven Antibody Discovery Platform and Progress a Pipeline of Assets Towards the Clinic". London. |
2024-05-21 |
| Scion Instruments. (5/21/24). "Press Release: SCION Instruments Has a New CEO". |
2024-05-21 |
| Accelerated Biosciences Corporation. (5/16/24). "Press Release: Accelerated Biosciences and Spanios Partner to Advance Therapeutic Design Across Solid Tumor Cancers". Houston, TX. |
2024-05-16 |
| Single Use Support GmbH. (5/15/24). "Press Release: Novo Holdings Acquires Majority Stake in Single Use Support". Kufstein. |
2024-05-15 |
| AC Immune S.A.. (5/13/24). "Press Release: AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease". Osaka, Cambride, MA & Lausanne. |
2024-05-13 |
| Memo Therapeutics AG. (5/7/24). "Press Release: Memo Therapeutics Increases Series C Financing to CHF 45 Million". Schlieren. |
2024-05-07 |
| Neurocare Group AG. (5/7/24). "Press Release: Neurocare Group AG Appoints Tariq El-Titi as Senior Vice President MENA, Strengthening Commitment to Middle East Health Sector". Dubai & Munich. |
2024-05-07 |
| Bar-Ilan University. (5/7/24). "Press Release: Opmed.ai Raises $15M". |
2024-05-07 |
| Biocytogen Pharmaceuticals (Beijing) Co., Ltd.. (5/6/24). "Press Release: Biocytogen Enters into Evaluation and Potential Licensing Agreement with BioCopy for TCR-mimic Antibodies". Beijing. |
2024-05-06 |
| Accelerated Biosciences Corporation. (5/2/24). "Press Release: Mekonos Enters Partnership Agreement with Accelerated Biosciences to Develop and Commercialize Engineered Human Trophoblast Stem Cells (hTSCs) for Biomanufacturing". Alameda, CA. |
2024-05-02 |
| Latus Bio, Inc.. (5/2/24). "Press Release: Latus Launches with State-of-the-Art Gene Therapy Development Technologies, Two Lead Product Candidates, and an Initial $54 Million in Series A Financing". Philadeliphia, PA. |
2024-05-02 |
| Remepy. (5/1/24). "Press Release: Remepy Launches with $15 Million in Funding to Bring First Hybrid Drug To Market". New York, NY. |
2024-05-01 |
| PeptiDream Inc.. (4/30/24). "Press Release: PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis". Kanagawa. |
2024-04-30 |
| Miltenyi Biotec B.V. & Co. KG. (4/29/24). "Press Release: Miltenyi Biotec and MiLaboratories Announce Strategic Partnership to Advance Next-generation Therapies". Bergisch Gladbach & San Francisco, CA. |
2024-04-29 |
| Smart Reporting GmbH. (4/22/24). "Press Release: Smart Reporting Successfully Closes Financing Round for 23 Million Euros". Munich. |
2024-04-22 |
| Outrun Therapeutics Ltd.. (4/18/24). "Press Release: Outrun Therapeutics Launches with a $10m Seed Financing from M Ventures and MP Healthcare Venture Management to Develop a Protein Stabilisation Pipeline". Dundee. |
2024-04-18 |
| Theolytics Ltd.. (4/17/24). "Press Release: Theolytics Successfully Closes Latest Financing Raising Total of £19M ($24.5M) and Welcomes Sound Bioventures as New Investor". Oxford. |
2024-04-17 |
| KBI Biopharma, Inc.. (4/15/24). "Press Release: KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer". Durham, NC. |
2024-04-15 |
| Naobios. (4/15/24). "Press Release: Naobios and Sumagen Sign Exclusive Partnership to Develop HIV Vaccine". Nantes. |
2024-04-15 |
| Nanoform Finland Oyj. (4/11/24). "Press Release: Nanoform Enters Exclusive Partnership with CBC to Bring Best-in-Class Nanomedicine Technology to Japan". Helsinki. |
2024-04-11 |
| Asahi Kasei Bioprocess. (4/11/24). "Press Release: Asahi Kasei Bioprocess and Axolabs Announce Strategic Partnership to Accelerate Oligonucleotide Therapeutics Development". Düsseldorf, Tokyo & New York, NY. |
2024-04-11 |
| TORL BioTherapeutics, LLC. (4/10/24). "Press Release: TORL BioTherapeutics Announces $158 Million Oversubscribed Series B-2 Financing to Advance the Clinical Development of its Novel Antibody-Drug Conjugate (ADC) Oncology Pipeline". Los Angeles, CA. |
2024-04-10 |
| Orgenesis Inc.. (4/10/24). "Press Release: Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility". Ormond Beach, FL & Germantown, |
2024-04-10 |
| Boehringer Ingelheim. (4/9/24). "Press Release: Boehringer Ingelheim Biopharmaceuticals China Receives Approval for Supply of EU and US Markets". Ingelheim & Shanghai. |
2024-04-09 |
| Sartorius AG. (4/9/24). "Press Release: Sartorius and TheWell Bioscience Partner to Enable more Accurate Predictions in Drug Discovery". Göttingen. |
2024-04-09 |
| Genmab A/S. (4/3/24). "Press Release: Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio". Copenhagen & Seattle, WA. |
2024-04-03 |
| Lonza Group AG. (4/2/24). "Press Release: Wolfgang Wienand, Currently CEO of Swiss CDMO Siegfried Holding AG, Will Become Chief Executive Officer of Lonza in the Summer of 2024". Basel. |
2024-04-02 |
| ERS Genomics Ltd.. (3/26/24). "Press Release: Key Charpentier/Doudna CRISPR Patent Upheld by China National Intellectual Property Administration". Dublin. |
2024-03-26 |
| A2 Biotherapeutics, Inc.. (3/25/24). "Press Release: A2 Bio Appoints James Robinson as New Chief Executive Officer and Member of the Board of Directors". Agoura Hills, CA. |
2024-03-25 |
| Engrail Therapeutics, Inc.. (3/19/24). "Press Release: Engrail Therapeutics Closes Oversubscribed $157M Series B Financing Round to Advance the Development of Transformational Therapies". San Diego, CA. |
2024-03-19 |
| Idorsia Ltd.. (3/18/24). "Press Release: Idorsia and Viatris Successfully Close the Transaction for the Global Research and Development Collaboration". Allschwil. |
2024-03-18 |
| ERS Genomics Ltd.. (3/13/24). "Press Release: Ricoh and ERS Genomics Enter into CRISPR/Cas9 License Agreement". Tokyo & Dublin. |
2024-03-13 |
| Sosei Group Corporation (d/b/a Sosei Heptares). (3/11/24). "Press Release: Boehringer Ingelheim and Sosei Heptares Join Forces to Develop First-in-class Treatments Targeting All Symptoms of Schizophrenia". Ingelheim, Tokyo & Cambridge. |
2024-03-11 |
| IZB Martinsried. (3/8/24). "Press Release: Christian Gnam Succeeds Dr. Peter Zobel as New Managing Director of the Biotechnology Innovation and Start-up Center (IZB)". Martinsried. |
2024-03-08 |
![[LSA] Life-Sciences-Asia.com - The Asia Life Sciences Web Portal](/images/basics/lsa-life-sciences-asia-portal-logo.svg){kind=logo}
Date![Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px](/banner/iito-business-intelligence-20220406-650-200-lse-life-sciences-europe.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
